C Bonithon-Kopp

Author PubWeight™ 37.63‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Effect of mutation type and location on clinical outcome in 1,013 probands with Marfan syndrome or related phenotypes and FBN1 mutations: an international study. Am J Hum Genet 2007 2.91
2 Increased risk of acute leukemia after adjuvant chemotherapy for breast cancer: a population-based study. J Clin Oncol 2000 1.59
3 Common carotid intima-media thickness predicts occurrence of carotid atherosclerotic plaques: longitudinal results from the Aging Vascular Study (EVA) study. Arterioscler Thromb Vasc Biol 2000 1.57
4 Contribution of molecular analyses in diagnosing Marfan syndrome and type I fibrillinopathies: an international study of 1009 probands. J Med Genet 2008 1.41
5 Ultrasonographic assessment of carotid wall characteristics and cognitive functions in a community sample of 59- to 71-year-olds. The EVA Study Group. Stroke 1996 1.15
6 Cross-sectional and 4-year longitudinal associations between brachial pulse pressure and common carotid intima-media thickness in a general population. The EVA study. Stroke 1999 1.14
7 Relations of cardiovascular risk factors to aortic pulse wave velocity in asymptomatic middle-aged women. Eur J Epidemiol 1993 1.11
8 Time trends in the treatment and survival of recurrences from colorectal cancer. Ann Oncol 2005 1.11
9 Effects of pregnancy on the inter-individual variations in blood levels of lead, cadmium and mercury. Biol Res Pregnancy Perinatol 1986 1.00
10 The new Ghent criteria for Marfan syndrome: what do they change? Clin Genet 2011 0.98
11 The very low penetrance of cystic fibrosis for the R117H mutation: a reappraisal for genetic counselling and newborn screening. J Med Genet 2009 0.96
12 Gender-related differences in MEN1 lesion occurrence and diagnosis: a cohort study of 734 cases from the Groupe d'etude des Tumeurs Endocrines. Eur J Endocrinol 2011 0.93
13 Clinical and mutation-type analysis from an international series of 198 probands with a pathogenic FBN1 exons 24-32 mutation. Eur J Hum Genet 2008 0.92
14 Prenatal exposure to lead and cadmium and psychomotor development of the child at 6 years. Neurobehav Toxicol Teratol 1986 0.88
15 Dietary patterns and the risk of colorectal adenoma recurrence in a European intervention trial. Eur J Cancer Prev 2005 0.88
16 Pathogenic FBN1 mutations in 146 adults not meeting clinical diagnostic criteria for Marfan syndrome: further delineation of type 1 fibrillinopathies and focus on patients with an isolated major criterion. Am J Med Genet A 2009 0.88
17 Weights at birth and in early infancy, systolic pressure, and left ventricular structure in subjects aged 8 to 24 years. Hypertension 1996 0.86
18 Systemic oxidative stress and cognitive performance in the population-based EVA study. Etude du Vieillissement Artériel. Free Radic Biol Med 1998 0.86
19 Non-steroidal anti-inflammatory drug prescribing patterns in general practice: comparison of a general practitioner-based survey and a pharmacy-based survey in France. Pharmacoepidemiol Drug Saf 2001 0.86
20 Low compliance with colonoscopic screening in first-degree relatives of patients with large adenomas. Aliment Pharmacol Ther 2006 0.86
21 Differential association of common carotid intima-media thickness and carotid atherosclerotic plaques with parental history of premature death from coronary heart disease : the EVA study. Arterioscler Thromb Vasc Biol 1999 0.85
22 Demographic and cardiovascular risk factors in relation to antioxidant status: the EVA Study. Int J Vitam Nutr Res 1998 0.85
23 Relation of serum elastase activity to ultrasonographically assessed carotid artery wall lesions and cardiovascular risk factors. The EVA study. Atherosclerosis 1996 0.85
24 National estimate of multiple sclerosis incidence in France (2001-2007). Mult Scler 2012 0.84
25 Haemostatic variables and menopausal status: influence of hormone replacement therapy. Thromb Haemost 1993 0.83
26 Hormonal influences on the relationships between body fatness, body fat distribution, lipids, lipoproteins, glucose and blood pressure in French working women. Atherosclerosis 1990 0.83
27 Residential magnetic field measurements in France: comparison of indoor and outdoor measurements. Bioelectromagnetics 1999 0.83
28 Non-steroidal anti-inflammatory and cytoprotective drug co-prescription in general practice. A general practitioner-based survey in France. Eur J Clin Pharmacol 2001 0.83
29 Annual diagnosis rate of superficial vein thrombosis of the lower limbs: the STEPH community-based study. J Thromb Haemost 2014 0.81
30 Microsatellite instability and intratumoural heterogeneity in 100 right-sided sporadic colon carcinomas. Br J Cancer 2002 0.81
31 A simulation model for evaluating the medical and economic outcomes of screening strategies for colorectal cancer. Eur J Cancer Prev 2003 0.80
32 Combined effects of blood pressure and body mass index on left ventricular structure in middle-aged males: cross-sectional and 2-year longitudinal results. J Hypertens 1995 0.79
33 Empirical study of the dependence of the results of multivariable flexible survival analyses on model selection strategy. Stat Med 2008 0.78
34 Is the management of hepatitis C patients appropriate? A population-based study. Aliment Pharmacol Ther 2005 0.78
35 Diet, fibers, and colon cancer. Adv Exp Med Biol 1999 0.78
36 Trends in gastric cancer incidence in a well-defined French population by time period and birth cohort. Eur J Cancer Prev 2002 0.77
37 Increased risk of atherosclerosis in women after the menopause. BMJ 1989 0.77
38 Written information to patients in clinical genetics: what's the impact? Eur J Med Genet 2011 0.76
39 Factor VII activation and menopausal status. Thromb Res 1990 0.76
40 [Extra-coronary atherosclerosis in documented coronary patients]. Arch Mal Coeur Vaiss 1998 0.75
41 Family history and risk of colorectal cancer: implications for screening programmes. J Med Screen 2000 0.75
42 Is factor VII activation in pregnant women relevant to fetal growth retardation? Thromb Res 1987 0.75
43 [Elastolysis, aging and atherogenesis]. C R Seances Soc Biol Fil 1995 0.75
44 [Detection of asymptomatic abdominal aorta in coronary disease patients having undergone coronarography]. J Mal Vasc 1995 0.75
45 Effect of fibre and calcium supplementation on adenoma recurrence and growth. IARC Sci Publ 2002 0.75
46 Heparin-associated thrombocytopenia in 24,401 patients with venous thromboembolism: findings from the RIETE Registry. J Thromb Haemost 2011 0.75
47 Natural history of patients developing thrombocytopenia while receiving anticoagulant therapy for venous thromboembolism. Int Angiol 2012 0.75
48 Time trends in first-diagnosis rates of colorectal adenomas: a 24-year population-based study. Aliment Pharmacol Ther 2008 0.75
49 Statement of severe trauma management in France; teachings of the FIRST study. Ann Fr Anesth Reanim 2013 0.75
50 Chemoprevention of colorectal cancer. Recent Results Cancer Res 1999 0.75